Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
08/1998
08/27/1998WO1998036770A1 Preparations for the treatment of metabolic syndrome containing human growth hormone in combination with a cortisol synthesis inhibitor
08/27/1998WO1998036769A1 Pulsatile delivery of leptin receptor ligands
08/27/1998WO1998036767A1 Modulation of the hypothalamic-pituitary-adrenal-adipose axis with leptin receptor ligands
08/27/1998WO1998036763A1 Treatment of infertility with leptin receptor ligands
08/27/1998WO1998036753A1 Tazarotene and corticosteroid treatment for psoriasis
08/27/1998WO1998036742A1 Methods and compositions for preventing and treating chronological aging in human skin
08/27/1998WO1998036733A2 Topical pharmaceutical composition comprising a cholinergic agent or a calcium channel blocker
08/27/1998WO1998036730A2 Compositions for treating acne rosacea
08/27/1998WO1998025640A3 Novel methods for testing inhibitors of paired helical filaments and uses for treatment of alzheimer's disease
08/27/1998DE19705538C1 Verfahren zur Trennung von Wirkstoffen in festen pharmazeutischen Zubereitungen A process for the separation of active ingredients in solid pharmaceutical preparations
08/27/1998CA2282467A1 Preparations for the treatment of metabolic syndrome containing human growth hormone in combination with a cortisol synthesis inhibitor
08/27/1998CA2282341A1 Modulation of the hypothalamic-pituitary-adrenal-adipose axis with leptin receptor ligands
08/27/1998CA2282325A1 Pulsatile delivery of leptin receptor ligands
08/27/1998CA2281919A1 Gel delivery vehicles for anticellular proliferative agents
08/27/1998CA2281888A1 Treatment of infertility with leptin receptor ligands
08/27/1998CA2281669A1 Human sodium-dependent phosphate cotransporter
08/27/1998CA2278577A1 Assay for disease related conformation of a protein
08/27/1998CA2276339A1 Transdermal pressure sensitive adhesive drug delivery system and pressure sensitive adhesive used therein
08/26/1998EP0860168A2 Use of central cannbinoid receptor CB1 agonists
08/26/1998EP0859787A1 G-protein coupled receptor hnfds78
08/26/1998EP0859630A1 Combination of temozolomide and alpha-ifn for the treatment of advanced cancer
08/26/1998EP0859611A1 Enhancement of erectile function with renin-angiotensin system inhibitors
08/26/1998EP0859608A1 Treating niddm with rxr agonists
08/26/1998EP0859604A1 Reduction of intravenously administered nanoparticulate-formulation-induced adverse physiological reactions
08/26/1998EP0859595A1 Therapeutic preparation for the transdermal administration of active substances
08/26/1998EP0859591A1 Use of at least one no synthase inhibitor for treating sensitive skin
08/26/1998CN1191568A Gene switch comprising ecdysone receptor
08/26/1998CN1191553A Method of detecting lung disease
08/26/1998CN1191491A 结缔组织生长因子 Connective tissue growth factor
08/26/1998CN1191484A Melatonin agonists for treating benign prostatic hyperplasia
08/26/1998CN1191481A Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereof
08/26/1998CA2225174A1 Rat cathepsin k polynucleotide & polypeptide sequence
08/25/1998US5798448 AL-1 neurotrophic factor antibodies
08/25/1998US5798388 Method and composition for treating mammalian diseases caused by inflammatory response
08/25/1998US5798386 Angiogenic lipid formulations
08/25/1998US5798380 Administering latrunculin a to enhance aqueous humor outflow in eye
08/25/1998US5798375 Treatment of arteriosclerosis and xanthoma
08/25/1998US5798363 Use for tachykinin antagonists to treat emesis
08/25/1998US5798355 Inhibitors of rotamase enzyme activity
08/25/1998US5798339 Treatment method for cancer
08/25/1998US5798246 Cyclic nucleotide phosphodiesterase
08/25/1998US5798090 Enhancement of the cellular immune response
08/25/1998US5797906 Retrograde tissue splitter and method
08/25/1998CA2031714C R-enantiomers of n-propargyl-1-aminoindan compounds, their preparation and pharmaceutical compositions containing them
08/20/1998WO1998036070A1 COMPOSITIONS AND METHODS FOR MODULATING CELLULAR NF-λB ACTIVATION
08/20/1998WO1998036069A1 Novel human mago nashi protein
08/20/1998WO1998036068A2 Human p24 vesicle proteins
08/20/1998WO1998036062A1 Neural cell adhesion molecule splicing variants
08/20/1998WO1998035985A1 Protein markers for lung cancer and use thereof
08/20/1998WO1998035701A1 Drug targeting
08/20/1998WO1998035693A2 Detection and modulation of the iaps and naip for the diagnosis and treatment of proliferative disease
08/20/1998WO1998035691A1 Treatment of infarcts through inhibition of nf-kappab
08/20/1998WO1998035685A1 Use of n-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy for treating hepatitis virus infections
08/20/1998WO1998035683A1 Compositions for the treatment of ards or irds containing 3-(cyclopropylmethoxy)-n-(3,5-dichloro-4-pyridinyl)-4-(difluoromethoxy)benzamide and lung surfactant
08/20/1998WO1998035676A1 A medicament against infertility and for increasing fertility
08/20/1998WO1998035674A1 Compositions for the inhibition of bone resorption
08/20/1998WO1998035667A1 Use of nitric oxid synthase inhibitors for the treatment of diabetes
08/20/1998WO1998035655A2 Method for separating active substances in solid pharmaceutical preparations
08/20/1998WO1998035554A2 Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms
08/20/1998WO1998014596A3 Disease associated protein tyrosine phosphatases
08/20/1998CA2282683A1 Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms
08/20/1998CA2281224A1 Treatment of infarcts through inhibition of nf-kappab
08/20/1998CA2280896A1 Novel human mago nashi protein
08/20/1998CA2280874A1 Bioreductive conjugate for targeting a therapeutic agent
08/20/1998CA2280871A1 Use of nitric oxide synthase inhibitors for the treatment of diabetes
08/20/1998CA2280722A1 Compositions for the inhibition of bone resorption
08/20/1998CA2280634A1 Human p24 vesicle proteins
08/20/1998CA2243984A1 Neural cell adhesion molecule splicing variants
08/19/1998EP0859055A1 Cloning of a novel g-protein coupled 7tm receptor
08/19/1998EP0859053A1 Novel G-protein coupled receptor (HTADX50)
08/19/1998EP0859052A1 Cloning of human GPR14 receptor
08/19/1998EP0858807A2 Use of dopamine receptor antagonists in palliative tumor therapy
08/19/1998EP0858346A1 Expression of cyclin g1 in tumors
08/19/1998EP0858340A1 Combination therapy for the treatment of diabetes and obesity
08/19/1998EP0858337A2 A pharmaceutical composition for the treatment of autoimmune diseases
08/19/1998EP0858336A1 Method and pharmaceutical composition for regulating lipid concentration
08/19/1998EP0858329A1 Novel stable liquid paracetamol compositions, and method for preparing same
08/19/1998CN1190991A Human chemokine beta-11 and human chemokine alpha-1
08/19/1998CN1190890A Cyclo-oxygenase inhibitor and amidine derivative salts, preparation method thereof, use thereof as drugs, and pharmaceutical compositions containing said salts
08/19/1998CN1190888A Methods and compositions for inhibiting 5 'alpha'=reductase activity
08/18/1998US5795908 Fkbp immunophilins for enzyme inhibitors
08/18/1998US5795861 Methods for regulating gastrointestinal motility
08/18/1998US5795758 DNA encoding histidyl tRNA synthetase variant from Streptococcus pneumoniae
08/18/1998US5795592 Calcium channel blocker
08/18/1998US5795575 Topical medicament which increases the number of capillaries in damaged skin
08/18/1998US5795574 Use of an extract from a non-photosynthetic filamentous bacterium and composition containing it
08/13/1998WO1998035061A2 Member of the tnf family useful for treatment and diagnosis of disease
08/13/1998WO1998035056A1 Identification of inhibitors of protein tyrosine kinase 2
08/13/1998WO1998035055A1 Method for identifying selective inhibitors of nitric oxide synthase
08/13/1998WO1998035048A2 Engineered protein kinases which can utilize modified nucleotide triphosphate substrates
08/13/1998WO1998035020A2 Methods for modulating hematopoiesis and vascular growth
08/13/1998WO1998034954A2 Ligands for discoidin domain receptor tyrosine kinases and complexes thereof
08/13/1998WO1998034932A1 Hiv integrase inhibitors
08/13/1998WO1998034643A1 Pharmaceutically active agents that impede the formation of amyloid by impeding the genesis or growth of dms
08/13/1998WO1998034632A1 Compounds and compositions for delivering active agents
08/13/1998WO1998034630A1 Use of gastrointestinal lipase inhibitors
08/13/1998WO1998034622A1 Methods for the administration of amifostine
08/13/1998WO1998034620A1 Methods for in vivo reduction of cyanide levels and compositions useful therefor
08/13/1998WO1998034615A1 Pharmaceutical composition for treatment of synaptic dysfunction comprising an oxime
08/13/1998WO1998034611A1 Methods and compositions for treating allergic asthma and other disorders using descarboethoxyloratadine
1 ... 1045 1046 1047 1048 1049 1050 1051 1052 1053 1054 1055 1056 1057 1058 1059 1060 1061 1062 1063 1064 1065 ... 1151